TITLE

Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs

AUTHOR(S)
Berno, Giulia; Zaccarelli, Mauro; Gori, Caterina; Tempestilli, Massimo; Antinori, Andrea; Perno, Carlo Federico; Pucillo, Leopoldo Paolo; D'Arrigo, Roberta
PUB. DATE
July 2014
SOURCE
BMC Medical Genetics;2014, Vol. 15 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Drug metabolism via the cytochrome P450 (CYP450) system has emerged as an important determinant in the occurrence of several drug interactions (adverse drug reactions, reduced pharmacological effect, drug toxicities). In particular, CYP3A4 and CYP3A5 (interacting with more than 60% of licensed drugs) exhibit the most individual variations of gene expression, mostly caused by single nucleotide polymorphisms (SNPs) within the regulatory region of the CYP3A4 and CYP3A5 genes which might affect the level of enzyme production. In this study, we sought to improve the performance of sensitive screening for CYP3A polymorphism detection in twenty HIV-1 infected patients undergoing lopinavir/ritonavir (LPV/r) monotherapy. Methods The study was performed by an effective, easy and inexpensive home-made Polymerase Chain Reaction Direct Sequencing approach for analyzing CYP3A4 and CYP3A5 genes which can detect both reported and unreported genetic variants potentially associated with altered or decreased functions of CYP3A4 and CYP3A5 proteins. Proportions and tests of association were used. Results Among the genetic variants considered, CYP3A4*1B (expression of altered function) was only found in 3 patients (15%) and CYP3A5*3 (expression of splicing defect) in 3 other patients (15%). CYP3A5*3 did not appear to be associated with decreased efficacy of LPV/r in any patient, since none of the patients carrying this variant showed virological rebound during LPV/r treatment or low levels of TDM. In contrast, low-level virological rebound was observed in one patient and a low TDM level was found in another; both were carrying CYP3A4*1B. Conclusions Our method exhibited an overall efficiency of 100% (DNA amplification and sequencing in our group of patients). This may contribute to producing innovative results for better understanding the inter-genotypic variability in gene coding for CYP3A, and investigating SNPs as biological markers of individual response to drugs requiring metabolism via the cytochrome P450 system.
ACCESSION #
97069640

 

Related Articles

  • Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy. Preissner, Sarah C.; Hoffmann, Michael F.; Preissner, Robert; Dunkel, Mathias; Gewiess, Andreas; Preissner, Saskia // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    The cytochrome P450 (CYP) enzymes are major players in drug metabolism. More than 2,000 mutations have been described, and certain single nucleotide polymorphisms (SNPs) have been shown to have a large impact on CYP activity. Therefore, CYPs play an important role in inter-individual drug...

  • Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer. Suzumura, Tomohiro; Kimura, Tatsuo; Kudoh, Shinzoh; Umelawa, Kanako; Nagata, Misato; Matsuura, Kuniomi; Tanaka, Hidenori; Mitsuoka, Shigeki; Yoshimura, Naruo; Kira, Yukimi; Nakai, Toshiyuki; Hirata, Kazuto // BMC Cancer;2012, Vol. 12 Issue 1, p568 

    Background: Rash, liver dysfunction, and diarrhea are known major adverse events associated with erlotinib and gefitinib. However, clinical trials with gefitinib have reported different proportions of adverse events compared to trials with erlotinib. In an in vitro study, cytochrome P450 (CYP)...

  • Allele and genotype frequencies of the polymorphic cytochrome P450 genes ( CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Yousef, Al-Motassem; Bulatova, Nailya; Newman, William; Hakooz, Nancy; Ismail, Said; Qusa, Hisham; Zahran, Farah; Anwar Ababneh, Nidaa; Hasan, Farah; Zaloom, Imad; Khayat, Ghada; Al-Zmili, Rawan; Naffa, Randa; Al-Diab, Ola // Molecular Biology Reports;Oct2012, Vol. 39 Issue 10, p9423 

    Drug metabolizing enzymes participate in the neutralizing of xenobiotics and biotransformation of drugs. Human cytochrome P450, particularly CYP1A1, CYP2C9, CYP2C19, CYP3A4 and CYP3A5, play an important role in drug metabolism. The genes encoding the CYP enzymes are polymorphic, and extensive...

  • Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events. Gaedigk, A.; Ndjountché, L.; Divakaran, K.; DiAnne Bradford, L.; Zineh, I.; Oberlander, T. F.; Brousseau, D. C.; McCarver, D. G.; Johnson, J. A.; Alander, S. W.; Riggs, K. Wayne; Leeder, J. Steven // Clinical Pharmacology & Therapeutics;Feb2007, Vol. 81 Issue 2, p242 

    Duplications and multiplications of active CYP2D6 genes can cause ultrarapid drug metabolism and lead to therapeutic failure. Multiple functional and non-functional duplication alleles have been further characterized. Duplications were detected by long-range polymerase chain reaction (PCR),...

  • Validation of a Proposed Warfarin Dosing Algorithm Based on the Genetic Make-Up of Egyptian Patients. Ekladious, Sherif M. M.; Issac, Marianne Samir M.; Sharaf, Sahar Abd El-Atty; Abou-Youssef, Hazem S. // Molecular Diagnosis & Therapy;Dec2013, Vol. 17 Issue 6, p381 

    Background: Warfarin is the most frequently prescribed oral anticoagulant worldwide. Due to its narrow therapeutic index and inter-patient variability in dose requirement, this drug has been considered an ideal target for personalised medicine. Several warfarin dosing algorithms have been...

  • Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis. Zhang, Z.; Liang, X. F.; Su, M. Q.; Yang, Q.; Li, L. P.; Zhang, X. H.; Wang, X. M.; Zhu, X. // DARU;Summer2011, Vol. 19 Issue 3, p210 

    Background and the purpose of the study: As a novel drug in the treatment of cardiac diseases, dl-praeruptorin A (Pd-la) is the major active component of traditional herbal medicine Peucedanum praeruptorum Dunn and is metabolized primarily via cytochrome P450 isozymes (CYP) 3A 1 and 3A2 in rats....

  • Classification and characterization of putative cytochrome P450 genes from Panax ginseng C. A. Meyer. Devi, Balusamy; Kim, Yu-Jin; Sathiyamoorthy, Subramaniyum; Khorolragchaa, Altanzul; Gayathri, Sathiyaraj; Parvin, Shohana; Yang, Dong-Uk; Selvi, Senthil; Lee, Ok; Lee, Sungyoung; Yang, Deok-Chun // Biochemistry (00062979);Dec2011, Vol. 76 Issue 12, p1347 

    In plants heme containing cytochrome P450 (P450) is a superfamily of monooxygenases that catalyze the addition of one oxygen atom from O into a substrate, with a substantial reduction of the other atom to water. The function of P450 families is attributed to chemical defense mechanism under...

  • Cytochrome P-450 Monooxygenase Gene Expression Supports a Multifactorial Origin for Acaricide Resistance in Ripicephalus microplus. Cossío-Bayúgar, Raquel; Miranda-Miranda, Estefan; Ortiz-Nájera, Alejandrina; Neri-Orantes, Salvador; Olvera-Valencia, Francisco // Research Journal of Parasitology;2008, Vol. 3 Issue 2, p59 

    This study was done with the objective of establishing a relationship between cytochrome P-450 gene expression and acaricide resistance levels in Mexican isolates of R. microplus, for that purpose the cytochrome P-450 expression levels were measured by real time PCR quantification on acaricide...

  • Zingiber zerumbet CYP71BA1 catalyzes the conversion of α-humulene to 8-hydroxy-α-humulene in zerumbone biosynthesis. Yu, Fengnian; Okamoto, Sho; Harada, Hisashi; Yamasaki, Kazuhisa; Misawa, Norihiko; Utsumi, Ryutaro // Cellular & Molecular Life Sciences;Mar2011, Vol. 68 Issue 6, p1033 

    Plant cytochrome P450s are involved in the biosynthesis of various classes of secondary metabolites. To elucidate the biosynthesis of zerumbone, a sesquiterpenoid with multiple potential anticancer properties, a family of P450 genes expressed in rhizomes of Zingiber zerumbet Smith, were cloned...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics